Progestin-inducible EDD E3 ubiquitin ligase binds to α4 phosphoprotein to regulate ubiquitination and degradation of protein phosphatase PP2Ac

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 254-261

  McDonald, William J ^a   Thomas, Lynn N ^a   Koirala, Samir ^a   Too, Catherine K L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

4 Phosphoprotein; 17 Estradiol; EDD E3 Ubiquitin ligase; PP2Ac; Progesterone; Prolactin

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; ESTRADIOL; PHOSPHATASE; PHOSPHOPROTEIN; PHOSPHOPROTEIN ALPHA4; PHOSPHOPROTEIN PHOSPHATASE 2AC; POLYADENYLIC ACID BINDING PROTEIN; PROGESTERONE; PROLACTIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3 IDENTIFIED BY DIFFERENTIAL DISPLAY; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME METABOLISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

17Β-ESTRADIOL; EDD E3 UBIQUITIN LIGASE; PP2AC; PROGESTERONE; PROLACTIN; Α4 PHOSPHOPROTEIN;

ANIMALS; BREAST NEOPLASMS; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME INDUCTION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MCF-7 CELLS; MUTANT PROTEINS; POLY(A)-BINDING PROTEINS; POLYUBIQUITIN; PROGESTINS; PROTEIN BINDING; PROTEIN PHOSPHATASE 2; PROTEOLYSIS; SUBSTRATE SPECIFICITY; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84886852155     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.09.033     Document Type: Article

References (38)

1. Aranda-Orgilles B., Rutschow D., Zeller R., Karagiannidis A.I., Kohler A., Chen C., Wilson T., Krause S., Roepcke S., Lilley D., Schneider R., Schweiger S. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1). J. Biol. Chem. 2011, 286:39945-39957.
2. Benavides M., Chow-Tsang L.F., Zhang J., Zhong H. The novel interaction between microspherule protein Msp58 and ubiquitin E3 ligase EDD regulates cell cycle progression. Biochim. Biophys. Acta 2013, 1833:21-32.
3. Boudreau R.T.M., Sangster S.M., Johnson L.M., Dauphinee S., Li A.W., Too C.K.L. Implication of α4 phosphoprotein and the rapamycin-sensitive mTOR pathway in prolactin receptor signalling. J. Endocrinol. 2002, 173:493-506.
4. Callaghan M.J., Russell A.J., Woollatt E., Sutherland G.R., Sutherland R.L., Watts C.K. Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene 1998, 17:3479-3491.
5. Chen J., Peterson R.T., Schreiber S.L. Alpha 4 associates with protein phosphatases 2A, 4, and 6. Biochem. Biophys. Res. Commun. 1998, 247:827-832.
6. Clancy J.L., Henderson M.J., Russell A.J., Anderson D.W., Bova R.J., Campbell I.G., Choong D.Y., Macdonald G.A., Mann G.J., Nolan T., Brady G., Olopade O.I., Woollatt E., Davies M.J., Segara D., Hacker N.F., Henshall S.M., Sutherland R.L., Watts C.K. EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene 2003, 22:5070-5081.
7. Clevenger C.V., Furth P.A., Hankinson S.E., Schuler L.A. The role of prolactin in mammary carcinoma. Endocri. Rev. 2003, 24:1-27.
8. Fuja T.J., Lin F., Osann K.E., Bryant P.J. Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon, DLG1, and EDD/hHYD in mammary ductal carcinoma. Cancer Res. 2004, 64:942-951.
9. Gingras A.C., Raught B., Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 2001, 15:807-826.
10. Gordon J., Hwang J., Carrier K.J., Jones C.A., Kern Q.L., Moreno C.S., Karas R.H., Pallas D.C. Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3. BMC Biochem. 2011, 12:54.
11. Han X., Du H., Massiah M.A. Detection and Characterization of the In Vitro E3 Ligase Activity of the Human MID1 Protein. J. Mol. Biol. 2011, 407:505-520.
12. Henderson M.J., Munoz M.A., Saunders D.N., Clancy J.L., Russell A.J., Williams B., Pappin D., Khanna K.K., Jackson S.P., Sutherland R.L., Watts C.K. EDD mediates DNA damage-induced activation of CHK2. J. Biol. Chem. 2006, 281:39990-40000.
13. Henderson M.J., Russell A.J., Hird S., Munoz M., Clancy J.L., Lehrbach G.M., Calanni S.T., Jans D.A., Sutherland R.L., Watts C.K. EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response. J. Biol. Chem. 2002, 277:26468-26478.
14. Inui S., Kuwahara K., Mizutani J., Maeda K., Kawai T., Nakayasu H., Sakaguchi N. Molecular cloning of a cDNA clone encoding a phosphoprotein component related to the Ig receptor-mediated signal transduction. J. Immunol. 1995, 154:2714-2723.
15. Inui S., Sanjo H., Maeda K., Yamamoto H., Miyamoto E., Sakaguchi N. Ig receptor binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 1998, 92:539-546.
16. Jackson P.K., Eldridge A.G., Freed E., Furstenthal L., Hsu J.Y., Kaiser B.K., Reimann J.D. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 2000, 10:429-439.
17. Jordan V.C., Morrow M. Tamoxifen, raloxifene, and the prevention of breast cancer. Endocrinol. Rev. 1999, 20:253-278.
18. Kozlov G., De Crescenzo G., Lim N.S., Siddiqui N., Fantus D., Kahvejian A., Trempe J.F., Elias D., Ekiel I., Sonenberg N., O'Connor-McCourt M., Gehring K. Structural basis of ligand recognition by PABC, a highly specific peptide-binding domain found in poly(A)-binding protein and a HECT ubiquitin ligase. Embo J. 2004, 23:272-281.
19. Kozlov G., Nguyen L., Lin T., De Crescenzo G., Park M., Gehring K. Structural basis of ubiquitin recognition by the ubiquitin-associated (UBA) domain of the ubiquitin ligase EDD. J. Biol. Chem. 2007, 282:35787-35795.
20. Lenoue-Newton M., Watkins G.R., Zou P., Germane K.L., McCorvey L.R., Wadzinski B.E., Spiller B.W. The E3 Ubiquitin Ligase- and Protein Phosphatase 2A (PP2A)-binding Domains of the Alpha4 Protein Are Both Required for Alpha4 to Inhibit PP2A Degradation. J. Biol. Chem. 2011, 286:17665-17671.
21. Ling S., Lin W.C. EDD inhibits ATM-mediated phosphorylation of p53. J. Biol. Chem. 2011, 286:14972-14982.
22. Liu E., Knutzen C.A., Krauss S., Schweiger S., Chiang G.G. Control of mTORC1 signaling by the Opitz syndrome protein MID1. Proc. Natl. Acad. Sci. USA 2011, 108:8680-8685.
23. Liu J., Prickett T.D., Elliott E., Meroni G., Brautigan D.L. Phosphorylation and microtubule association of the Opitz syndrome protein Mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4. Proc. Natl. Acad. Sci. USA 2001, 98:6650-6655.
24. Mangus D.A., Evans M.C., Jacobson A. Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression. Genome Biol. 2003, 4:223.
25. Mansfield E., Hersperger E., Biggs J., Shearn A. Genetic and molecular analysis of hyperplastic discs, a gene whose product is required for regulation of cell proliferation in Drosophila melanogaster imaginal discs and germ cells. Dev. Biol. 1994, 165:507-526.
26. McConnell J.L., Watkins G.R., Soss S.E., Franz H.S., McCorvey L.R., Spiller B.W., Chazin W.J., Wadzinski B.E. Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination. Biochemistry 2010, 49:1713-1718.
27. McDonald W.J., Sangster S.M., Moffat L.D., Henderson M.J., Too C.K.L. Alpha4 phosphoprotein interacts with EDD E3 ubiquitin ligase and poly(A)-binding protein. J. Cell Biochem. 2010, 110:1123-1129.
28. McGuire W.L., Osborne C.K., Clark G.M., Knight W.A. Steroid hormone receptors and carcinoma of the breast. Am. J. Physiol. 1982, 243. E99-102.
29. Munoz M.A., Saunders D.N., Henderson M.J., Clancy J.L., Russell A.J., Lehrbach G., Musgrove E.A., Watts C.K., Sutherland R.L. The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints. Cell Cycle 2007, 6:3070-3077.
30. Murata K., Wu J., Brautigan D.L. B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc. Natl. Acad. Sci. USA 1997, 94:10624-10629.
31. Nanahoshi M., Nishiuma T., Tsujishita Y., Hara K., Inui S., Sakaguchi N., Yonezawa K. Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42. Biochem. Biophys. Res. Commun. 1998, 251:520-526.
32. O'Brien P.M., Davies M.J., Scurry J.P., Smith A.N., Barton C.A., Henderson M.J., Saunders D.N., Gloss B.S., Patterson K.I., Clancy J.L., Heinzelmann-Schwarz V.A., Murali R., Scolyer R.A., Zeng Y., Williams E.D., Scurr L., Defazio A., Quinn D.I., Watts C.K., Hacker N.F., Henshall S.M., Sutherland R.L. The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. Br. J. Cancer 2008, 98:1085-1093.
33. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 2001, 70:503-533.
34. Raught B., Gingras A.C., Sonenberg N. The target of rapamycin (TOR) proteins. Proc. Natl. Acad. Sci. USA 2001, 98:7037-7044.
35. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell 2000, 103:253-262.
36. Trockenbacher A., Suckow V., Foerster J., Winter J., Krauss S., Ropers H.H., Schneider R., Schweiger S. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat. Genet. 2001, 29:287-294.
37. Yang J., Roe S.M., Prickett T.D., Brautigan D.L., Barford D. The structure of Tap42/alpha4 reveals a tetratricopeptide repeat-like fold and provides insights into PP2A regulation. Biochemistry 2007, 46:8807-8815.
38. Zolnierowicz S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem. Pharmacol. 2000, 60:1225-1235.